-
Je něco špatně v tomto záznamu ?
Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype
Y. Mazurová, I. Gunčová, I. Látr, E. Rudolf
Jazyk angličtina Země Spojené arabské emiráty
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- buněčná diferenciace fyziologie MeSH
- degenerace nervu patologie MeSH
- fenotyp MeSH
- Huntingtonova nemoc patologie patofyziologie terapie MeSH
- lidé MeSH
- nervové kmenové buňky fyziologie transplantace MeSH
- neurogeneze fyziologie MeSH
- neurony patologie fyziologie MeSH
- nucleus caudatus patologie patofyziologie MeSH
- proliferace buněk MeSH
- savci MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The evidence for the existence of neurogenesis in the adult mammalian brain, including humans is now widely accepted. Despite the fact that adult neural stem cells appear to be very promising, a wide range of their unrevealed properties, abilities but also limitations under physiological and especially pathological conditions still need to be investigated and explained. Huntington's disease (HD) is characterized by successive degeneration of relatively well-defined neuronal population. Moreover, the most affected region, the caudate nucleus, is adjacent to the subependymal zone (SEZ) neurogenic region. Therefore, the possibility to harness the endogenous neural stem cell capacity for repairing, or at least restricting, the fatal neurodegenerative process in HD patients using promoted neurogenesis in the adult SEZ represent the exciting new possibility in clinical management of this disorder. On the other hand, many questions have to be answered before neuronal replacement therapies using endogenous precursors become a reality, particularly in relation to neurodegenerative diseases. Fundamental for all experimental, functional and future clinical studies is detailed morphological description of structures involved in the process of neurogenesis. The objectives of this review are to describe neurogenesis in the adult murine and human brain (with particular emphasis to morphological aspects of this process) and to determine to what extent it is affected in animal models of HD and in the human HD brain. Due to very limited evidence referring to the impact of striatal pathology of HD phenotype on the adult neurogenesis in the SEZ, some results gained from our studies on two rat models of HD, i.e. the neurotoxic lesion and transgenic HD rats, and on human HD brains are discussed.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022189
- 003
- CZ-PrNML
- 005
- 20160304124258.0
- 007
- ta
- 008
- 120806s2011 ts f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.2174/187152711795563967 $2 doi
- 035 __
- $a (PubMed)21495959
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ts
- 100 1_
- $a Mazurová, Yvona, $u Department of Histology and Embryology, Charles University in Prague, Faculty of Medicine in Hradec Králové, Simkova 870, P.O. Box 38, 500 38 Hradec Králové, Czech Republic $d 1951- $7 xx0054511
- 245 10
- $a Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype / $c Y. Mazurová, I. Gunčová, I. Látr, E. Rudolf
- 520 9_
- $a The evidence for the existence of neurogenesis in the adult mammalian brain, including humans is now widely accepted. Despite the fact that adult neural stem cells appear to be very promising, a wide range of their unrevealed properties, abilities but also limitations under physiological and especially pathological conditions still need to be investigated and explained. Huntington's disease (HD) is characterized by successive degeneration of relatively well-defined neuronal population. Moreover, the most affected region, the caudate nucleus, is adjacent to the subependymal zone (SEZ) neurogenic region. Therefore, the possibility to harness the endogenous neural stem cell capacity for repairing, or at least restricting, the fatal neurodegenerative process in HD patients using promoted neurogenesis in the adult SEZ represent the exciting new possibility in clinical management of this disorder. On the other hand, many questions have to be answered before neuronal replacement therapies using endogenous precursors become a reality, particularly in relation to neurodegenerative diseases. Fundamental for all experimental, functional and future clinical studies is detailed morphological description of structures involved in the process of neurogenesis. The objectives of this review are to describe neurogenesis in the adult murine and human brain (with particular emphasis to morphological aspects of this process) and to determine to what extent it is affected in animal models of HD and in the human HD brain. Due to very limited evidence referring to the impact of striatal pathology of HD phenotype on the adult neurogenesis in the SEZ, some results gained from our studies on two rat models of HD, i.e. the neurotoxic lesion and transgenic HD rats, and on human HD brains are discussed.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nucleus caudatus $x patologie $x patofyziologie $7 D002421
- 650 _2
- $a buněčná diferenciace $x fyziologie $7 D002454
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Huntingtonova nemoc $x patologie $x patofyziologie $x terapie $7 D006816
- 650 _2
- $a savci $7 D008322
- 650 _2
- $a degenerace nervu $x patologie $7 D009410
- 650 _2
- $a nervové kmenové buňky $x fyziologie $x transplantace $7 D058953
- 650 _2
- $a neurogeneze $x fyziologie $7 D055495
- 650 _2
- $a neurony $x patologie $x fyziologie $7 D009474
- 650 _2
- $a fenotyp $7 D010641
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Němečková, Ivana $7 xx0208646
- 700 1_
- $a Látr, Ivan, $d 1943- $7 xx0062309
- 700 1_
- $a Rudolf, Emil, $d 1970- $7 xx0076300
- 773 0_
- $w MED00173402 $t CNS & neurological disorders drug targets $x 1996-3181 $g Roč. 10, č. 4 (2011), s. 486-499
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21495959 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20160304124310 $b ABA008
- 999 __
- $a ok $b bmc $g 944102 $s 779486
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 10 $c 4 $d 486-499 $i 1996-3181 $m CNS & neurological disorders. Drug targets $n CNS Neurol Disord Drug Targets $x MED00173402
- LZP __
- $b NLK111 $a Pubmed-20120806/12/01